Westchester Capital Management (New York)’s Orion Biotech Opportunities Corp. Class A Ordinary Share ORIA Stock Holding History

Westchester Capital Management (New York)’s Portfolio ORIA Stock Details ORIA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-951,768	Closed	-$9.74M	–	419
2023 Q1	$9.74M	Buy	951,768 +926,753	+3,705%	+$9.41M	0.3%	102
2022 Q4	$251K	Buy	+25,015	New	+$249K	0.01%	365

Westchester Capital Management (New York)'s ORIA Position: Q2 2023 in Review

Westchester Capital Management (New York) sold out of Orion Biotech Opportunities Corp. Class A Ordinary Share (ORIA) in Q2 2023, closing a stake of 951,768 shares — an estimated $9.74M sold.

Westchester Capital Management (New York) first reported a position in ORIA in Q4 2022 and held it in 2 quarters. The position peaked at $9.74M in Q1 2023. 0 funds tracked by Wall St. Rank hold ORIA as of Q2 2023.

Westchester Capital Management (New York) reported no remaining Orion Biotech Opportunities Corp. Class A Ordinary Share position as of Q2 2023 after selling out during the quarter.
Westchester Capital Management (New York) sold 951,768 Orion Biotech Opportunities Corp. Class A Ordinary Share shares in Q2 2023, an estimated $9.74M.
Westchester Capital Management (New York) first reported a position in Orion Biotech Opportunities Corp. Class A Ordinary Share in Q4 2022 and held it in 2 quarters.
Westchester Capital Management (New York)'s Orion Biotech Opportunities Corp. Class A Ordinary Share position peaked at $9.74M in Q1 2023.
0 funds tracked by Wall St. Rank held Orion Biotech Opportunities Corp. Class A Ordinary Share as of Q2 2023.

Based on Westchester Capital Management (New York)'s 13F filing for Q2 2023, filed 14 Aug 2023.